At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
XprESS +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
XprESS Eustachian Tube Dilation Study
In Brief
A clinical study evaluating XprESS and Control for Eustachian Tube Dysfunction. Completed, enrolled 60 participants across 5 sites.
Detailed Summary
Study to assess the safety and efficacy of the XprESS device for transnasal Eustachian tube dilation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEustachian Tube Dysfunction
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartFeb 2015
First PostedMar 2015
Primary CompletionMar 2017
Study CompletionOct 2017
TodayJul 2026
First PostedMar 18, 2015
Enrollment StartFeb 1, 2015
Primary CompletionMar 1, 2017
Study CompletionOct 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 11.3 years ago
Interventions
XprESSdevice
Balloon dilation of the Eustachian tube
Controlother
Continued medical management